跳至主要内容
临床试验/NCT03118310
NCT03118310已完成2 期

Treatment of NAFLD With Two Different Diets

Karolinska University Hospital2 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2017年4月6日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
74
试验地点
2
主要终点
Liver fat

研究概览

简要总结

The impact of popular diets on liver-related health is unclear. In this randomized, controlled trial, patients with NAFLD will be randomized to one of two popular diets or a placebo diet.

详细描述

Subjects will include patients with MRI-verified NAFLD, with no concurrent liver diseases. Randomization will be done to either a control diet, the 5:2 diet or a low-carb-high-fat diet. The subjects will follow the diet for three months, after which a new MRI is performed. Main outcomes measure is reduction in liver fat.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Known NAFLD

排除标准

  • Other forms of liver disease
  • Bolus insulin treatment
  • Cirrhosis

结局指标

主要结局

Liver fat

时间窗: Three months

MRI-measured liver fat content

次要结局

未报告次要终点

研究者

发起方
Karolinska University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hannes Hagström

Primary Investigator

Karolinska University Hospital

研究点 (2)

Loading locations...

相似试验